clofibric acid has been researched along with Impotence in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Endothelial dysfunction and a reduced generation or bioavailability of NO have emerged as major pathophysiological mechanisms in ED." | 2.44 | Dyslipidemia as a risk factor for erectile dysfunction. ( Mikhailidis, DP; Paraskevas, KI; Vrentzos, GE, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vrentzos, GE | 1 |
| Paraskevas, KI | 1 |
| Mikhailidis, DP | 1 |
1 review available for clofibric acid and Impotence
| Article | Year |
|---|---|
Dyslipidemia as a risk factor for erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Clofibric Acid; Cyclic Nucleotide Phosphodiesteras | 2007 |